Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $2.78 billion. The enterprise value is $5.28 billion.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 314.08 million shares outstanding. The number of shares has increased by 24.71% in one year.
| Current Share Class | 314.08M |
| Shares Outstanding | 314.08M |
| Shares Change (YoY) | +24.71% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 46.56% |
| Owned by Institutions (%) | 43.59% |
| Float | 167.84M |
Valuation Ratios
The trailing PE ratio is 822.66 and the forward PE ratio is 12.37.
| PE Ratio | 822.66 |
| Forward PE | 12.37 |
| PS Ratio | 0.96 |
| Forward PS | 1.18 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.25 |
| P/OCF Ratio | 7.91 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.45, with an EV/FCF ratio of 19.50.
| EV / Earnings | 1,565.35 |
| EV / Sales | 1.85 |
| EV / EBITDA | 8.45 |
| EV / EBIT | 13.91 |
| EV / FCF | 19.50 |
Financial Position
The company has a current ratio of 1.43
| Current Ratio | 1.43 |
| Quick Ratio | 0.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.00 |
| Debt / FCF | 9.53 |
| Interest Coverage | 1.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 6.85% |
| Return on Invested Capital (ROIC) | 9.03% |
| Return on Capital Employed (ROCE) | 16.40% |
| Revenue Per Employee | $343,725 |
| Profits Per Employee | $407 |
| Employee Count | 8,300 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.01 |
Taxes
In the past 12 months, AMRX has paid $38.06 million in taxes.
| Income Tax | 38.06M |
| Effective Tax Rate | 42.62% |
Stock Price Statistics
The stock price has increased by +15.56% in the last 52 weeks. The beta is 1.12, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +15.56% |
| 50-Day Moving Average | 8.02 |
| 200-Day Moving Average | 8.07 |
| Relative Strength Index (RSI) | 70.00 |
| Average Volume (20 Days) | 1,431,773 |
Short Selling Information
The latest short interest is 5.41 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 5.41M |
| Short Previous Month | 5.35M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 3.22% |
| Short Ratio (days to cover) | 3.12 |
Income Statement
In the last 12 months, AMRX had revenue of $2.85 billion and earned $3.38 million in profits. Earnings per share was $0.01.
| Revenue | 2.85B |
| Gross Profit | 1.07B |
| Operating Income | 379.82M |
| Pretax Income | -55.01M |
| Net Income | 3.38M |
| EBITDA | 625.18M |
| EBIT | 379.82M |
| Earnings Per Share (EPS) | $0.01 |
Full Income StatementBalance Sheet
The company has $75.28 million in cash and $2.58 billion in debt, giving a net cash position of -$2.51 billion or -$7.98 per share.
| Cash & Cash Equivalents | 75.28M |
| Total Debt | 2.58B |
| Net Cash | -2.51B |
| Net Cash Per Share | -$7.98 |
| Equity (Book Value) | -46.73M |
| Book Value Per Share | -0.36 |
| Working Capital | 477.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $351.08 million and capital expenditures -$80.20 million, giving a free cash flow of $270.88 million.
| Operating Cash Flow | 351.08M |
| Capital Expenditures | -80.20M |
| Free Cash Flow | 270.88M |
| FCF Per Share | $0.86 |
Full Cash Flow StatementMargins
Gross margin is 37.43%, with operating and profit margins of 13.31% and 0.12%.
| Gross Margin | 37.43% |
| Operating Margin | 13.31% |
| Pretax Margin | 3.13% |
| Profit Margin | 0.12% |
| EBITDA Margin | 21.91% |
| EBIT Margin | 13.31% |
| FCF Margin | 9.49% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.71% |
| Shareholder Yield | -24.71% |
| Earnings Yield | 0.12% |
| FCF Yield | 9.76% |
Dividend DetailsAnalyst Forecast
The average price target for AMRX is $11.50, which is 30.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 30.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMRX has an Altman Z-Score of 1.56 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.56 |
| Piotroski F-Score | 8 |
